The development of electromechanical and robotic devices has progressively enriched neurorehabilitation. Social, clinical, and technological drivers have supported this technological growth consisting of three main mechanical categories: exoskeleton, end-effector, and soft robotics. Scant literature has been focused on gait and balance rehabilitation of patients with Parkinson’ Disease based on neurophysiological knowledge of functional recovery in neurological disability, reporting promising effects. However, no specific devices have been implemented for movement disorders. Collaboration between engineers, therapists, and clinical neurophysiologists/neurorehabilitation scientists is required to develop successful robotic devices. As to the existing ones, clinicians should adopt the robot-assisted rehabilitation protocols for patients with Parkinson's Disease according to the presence of disease-specific symptoms and rehabilitation aims. © 2024 Elsevier Inc. All rights reserved.
Chapter 16 - Robotics and exoskeletons: Are we close to daily clinical implementation?
Gandolfi, Marialuisa;Salaorni, Francesca
2024-01-01
Abstract
The development of electromechanical and robotic devices has progressively enriched neurorehabilitation. Social, clinical, and technological drivers have supported this technological growth consisting of three main mechanical categories: exoskeleton, end-effector, and soft robotics. Scant literature has been focused on gait and balance rehabilitation of patients with Parkinson’ Disease based on neurophysiological knowledge of functional recovery in neurological disability, reporting promising effects. However, no specific devices have been implemented for movement disorders. Collaboration between engineers, therapists, and clinical neurophysiologists/neurorehabilitation scientists is required to develop successful robotic devices. As to the existing ones, clinicians should adopt the robot-assisted rehabilitation protocols for patients with Parkinson's Disease according to the presence of disease-specific symptoms and rehabilitation aims. © 2024 Elsevier Inc. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.